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Abstract
Angiogenesis is a complex process where biological signals, such as the activation of
signalling pathways by the binding of VEGF to its receptors at the cell membrane,
are converted into mechanical forces originating cell movement. The endothelial
cells then re-organize spatially into tubular structures that are able to support the
flow of blood and that respond to blood pressure and shear stress by changing
their number, shape and size. Therefore, a mathematical description of sprouting
angiogenesis has to consider biological signals as well as relevant physical processes.
In this thesis, we model sprouting events in angiogenesis using a continuum
model that takes into account the tissue elasticity and the forces exerted by the
cells in the sprout. We demonstrate that the endothelial cell proliferation has to
be regulated by the local mechanical stress for a well-formed vascular sprout. The
force exerted at the tip cell induces an increase in the stress, which determines the
locations with higher endothelial cell proliferation. The model also permits a new
look into how anastomosis events are controlled by the local tissue displacements.
Our results highlight the ability of mathematical models to suggest relevant
hypotheses with respect to the role of forces in sprouting, hence underlining the
necessary collaboration between modelling and molecular biology techniques to
improve our knowledge of the angiogenesis process.
Keywords: angiogenesis, VEGF, hybrid modelling, phase field model, elasticity,
mechanical interactions, proliferation
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Resumo
A angioge´nese e´ um processo complexo capaz de originar movimento celular atrave´s
da conversa˜o de sinais biolo´gicos em forc¸as mecaˆnica. Esses sinais sa˜o originados
com a ligac¸a˜o do VEGF aos seus receptores na membrana celular. Depois disso,
as ce´lulas endoteliais reorganizam-se espacialmente em estruturas tubulares que
sa˜o capazes de suportar o fluxo de sangue e que respondem a` pressa˜o sangu´ınea
e shear stress alterando o seu nu´mero, forma e tamanho. Desta modo, uma de-
scric¸a˜o matema´tica da sprouting angiogenesis tem que ter em considerac¸a˜o sinais
biolo´gicos, assim como processos f´ısicos relevantes.
Modelamos os eventos da sprouting angiogenesis usando um modelo cont´ınuo
que tem em conta a elasticidade do tecido e as forc¸as exercidas pelas ce´lulas no
sprout. Para ale´m disso, demonstramos que a proliferac¸a˜o das ce´lulas endoteliais
tem de ser regulada pelo stress mecaˆnico local para um sprout bem formado.
A forc¸a exercida na ce´lula de ponta, chamada tip cell, induz um aumento do
stress, o que determina os locais com maior proliferac¸a˜o endotelial. O modelo
tambe´m permite um novo olhar sobre a forma como os eventos de anastomose sa˜o
controlados pelos deslocamentos locais do tecido.
Os nossos resultados destacam a habilidade que os modelos matema´ticos teˆm
para sugerir hipo´teses relevantes no que toca ao papel das forc¸as no sprouting. E´
tambe´m sublinhanda a colaborac¸a˜o necessa´ria entre a modelac¸a˜o e as te´cnicas de
biologia molecular para melhorar o actual estado da arte.
Palavras-chave: angioge´nese, VEGF, modelac¸a˜o h´ıbrida, modelo de interface
difusa, elasticidade, interac¸o˜es mecaˆnicas, proliferac¸a˜o
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Chapter 1
Introduction
1.1 Motivation and goals
Blood vessel growth is essential in complex animal species. Only the establishment
of a vascular system guarantees the success of basic body functions. A vascular
system enables the transport of oxygen and nutrients to all the body cells. Not
less important is the elimination of toxic byproducts resultant from metabolic
activity2.
Not surprisingly, excessive or insufficient stimulus for vessel growth is related to
the onset and progression of over 50 different diseases such as cancer, rheumatoid
arthritis, diabetic retinopathy and ischemic heart disease2,3.
Recognition that control of blood vessel growth (angiogenesis) could lead to
cancer therapies stimulated intensive research in the field. While by 1970 only two
manuscripts dealing with angiogenesis had been published4, currently this number
reaches more than 72 000 in total.
There are evidences that increased tumour vascularization is associated with ad-
vanced stages of various solid tumours5. Tumour-induced angiogenesis can persist
for years, involving a disorganized, inefficient and leaky vasculature6. This vascu-
lature supplies the tumour with nutrients and growth factors enabling its growth
1
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and can be used by cancer cells that detach from the primary tumour to move and
metastasize to remote organs6,7. Naively, one could think that starving tumours
by destroying their blood supply would arrest their growth. However, after years
of research, the initial work using anti-angiogenic drugs alone did not translate
into long-term positive clinical results for cancer patients8. This is explained by
the fact that a complete inhibition of angiogenesis promotes hypoxia (state of oxy-
gen shortage) within the tumour, that can increase the occurrence of aggressive
migrating tumour cell phenotypes - it is like a selection of the most aggressive
types6. Instead, an alternative strategy has emerged: the use of anti-angiogenic
drugs to normalize the tumour vasculature, thereby improving the delivery of
chemotherapeutic drugs and oxygen to tumour tissues, which increases the effi-
ciency of radiation therapy9. This demands treatments with specific amounts of
anti-angiogenic agents (figure 1.1).
Figure 1.1: Blood Vessels changes in response to anti-angiogenic therapy. (a) Normal
vessels. (b) Dilated, tortuous and disorganized vessels from a cancer. (c)
Normalized cancer vasculature due to angiogenic inhibitors. (d) Angio-
genic inhibitors can cause, eventually, the death of an increased number
of vessels.9.
Predicting the correct levels of anti-angiogenic agents that will lead to the de-
sired results requires an in-depth understanding of both the mechanical and bio-
logical aspects of pathological angiogenesis. Our final aim is to achieve this task by
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integrating the various aspects of this challenging problem through mathematical
and computational modelling.
Although there was a time when computational models were developed and
implemented without validation with real experiment data, nowadays this synergy
between research areas is a requirement to have biological acceptance10. Following
this, I would like to highlight the interdisciplinarity of this project. To deal with
the complexity underlying the fine regulation of new blood vessel formation, we
need to repeatedly traverse an iterative cycle of collaborative interaction between
biology, theoretical modelling, computational simulation and experiments that
directly test and parametrize the model.
We aim to understand more about the mechanical factors that mediate blood
vessel formation and remodelling, because their mechanisms remain poorly under-
stood11. To succeed with doing so, we use a multi-scale phase-field model that
combines the benefits of continuum physics description and the capability of track-
ing individual cells. The first goal of this thesis is to simulate our mathematical
model, which takes into account elasticity, proliferation and migration, in the C
language. The next steps are to parametrize the model according to the literature,
start walking towards anastomosis and include blood pressure. In order to create
anastomosis, reformulations must be done in the model. For this reason, one of the
first goals planned for this thesis, the inclusion of blood pressure, was substituted
by improvements in the model.
Personally, I find this project a great opportunity to apply the transversal
knowledge that I acquired during the Biomedical Engineering degree. Besides,
numerical simulation is an important knowledge that is not confined to natural
processes. In what gives respect to health, it is believed that until the end of the
century computer simulation could become ’integral’ in the diagnosis, treatment,
or prevention of disease.
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1.2 Sprouting Angiogenesis
1.2.1 General aspects
In the embryo, the primitive vasculature develops through vasculogenesis, the de
novo blood vessel generation from vascular progenitor cells. Vasculogenesis is
the earliest morphogenetic process of vascular development and occurs exclusively
during the early stages of the embryonic development, allowing the organs to have
the necessary oxygen to grow12,13. It consists of the differentiation of angioblasts
(the precursors of endothelial cells) into blood islands, which then fuse to form
primitive capillary plexuses13. These plexuses subsequently grow so as to reach
another tissues (see figure 1.2). Notice that metabolically active tissues need to
be closer than few hundred micrometers from a blood capillary4. This growth of
capillaries from pre-existing microvasculature occurs through angiogenesis and is
influenced by various biochemical and biomechanical factors14.
Figure 1.2: Schematic overview of vasculogenesis and angiogenesis. (a) Endothelial
cell precursors coalesce and differentiate into endothelial cells. (b) Prim-
itive vasculogenic networks are formed (vasculogenesis). (c) Remodelling
of the networks through angiogenesis, which involves sprouting and in-
tussusception, resulting in the formation of microvessels15.
Angiogenesis is crucial in many physiological processes including embryonic de-
velopment, wound healing, fracture repair, folliculogenesis, ovulation, pregnancy
and exercise-induced vascular adaptation13,16. Angiogenesis is also particularly
relevant in the following two important situations. First, angiogenesis occurs dur-
ing tumour growth providing additional nourishment required for the tumour to
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proliferate. Second, it is essential for tissue engineering purposes where is required
to predict and control capillary development in scaffolds during in vitro tissue
development14,16.
Endothelial cells (ECs) constitute the inner layer of blood vessels. They have
an active role in angiogenesis, being primarily responsible for capillary growth,
migration, and organization of vessel lumens6,17. During angiogenesis, each EC
residing in a vessel wall integrates local signals to determine whether it:
• remains quiescent;
• participates in vessel dilation or contraction (it may imply the EC prolifer-
ation or apoptosis, respectively);
• undergoes morphogenesis to form an angiogenic sprout or participate in in-
tussusceptive vessel alteration18.
The sprouting and intussusceptive ways of altering the vascular plexus are
very different from each other (see figure 1.3). In sprouting angiogenesis, ECs
are able to project into the extracellular matrix (ECM), disrupt the basement
membrane and invade new tissues, reaching areas of tissues previously devoid of
blood vessels. This is essential, for example, in wound healing. On the other hand,
intussusceptive angiogenesis is much quicker. It results in the formation of two
lumens from a single vessel by intravascular septation. This means there is little
or no dependence on cell proliferation and migration and that is why it plays a
proeminent role in vascular development in processes where growth is fast and
resources are limited. Moreover, there is maintenance of organ functions because
there is no need for membrane disruption4,19.
In this work we focus on sprouting angiogenesis type. This process is better
understood having been discovered nearly 200 years ago, while intussusceptive
(also known as nonsprouting) angiogenesis was discovered by about two decades
ago and its molecular mechanisms are not yet clearly understood4,7. No particular
molecule has been linked to this process as opposed to, for example, VEGF for
sprouting angiogenesis7.
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Figure 1.3: Sprouting and intussusceptive angiogenesis: comparison between their
early stages. In sprouting angiogenesis, the disrupted membrane (dotted
lines) allow ECs to migrate and proliferate to form a new vascular tube. In
contrast, in intussusception the vessel wall extends into the lumen causing
a single vessel to split in two, with an intact basement membrane20.
1.2.2 Signalling pathways
Sprouting angiogenesis is initiated in poorly perfused tissues when oxygen sensing
mechanisms detect a level of hypoxia that demands the formation of new blood
vessels to satisfy the metabolic requirements of parenchymal cells. Most types of
parenchymal cells (myocytes, hepatocytes, neurons, astrocytes, etc.) respond to a
hypoxic environment by secreting a key proangiogenic growth factor called vascular
endothelial growth factor (VEGF)4. This protein is the best studied vascular
morphogen and has the ability to trigger the entire sequence of events leading to
new vessel growth. It also promotes vasodilation21. Besides, it does not appear to
exist other redundant growth factor mechanisms that are able to replace the role of
VEGF in hypoxia-induced angiogenesis4. In the presence of VEGF, sprouting cells
organize hierarchically into leading ”tip” and trailing ”stalk” cells. Endothelial tip
cells lead sprouting vessels, extend filopodia, and migrate in response to gradients
of VEGF. In contrast, adjacent stalk cells trail the tip cells, generate the trunk of
new vessels, and critically maintain connectivity with parental vessels (see figure
1.4)22.
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Figure 1.4: Phenotypic and molecular differences between endothelial tip and stalk
cells. Tip cells (green) guide each vascular sprout stimulated by an extra-
cellular VEGF gradient (orange), followed by the stalk cells (purple)23.
Of the vast number of growth factors and signalling pathways that take part
on the angiogenic cascade, angiopoietins (Ang/Tie2) and platelet-derived growth
factors (PDGF-B/PGDFR-B) coordinate with VEGF to play an important regu-
lating part in sprouting angiogenesis and maturation24. This can be seen either
in figure 1.5 and figure 1.6.
We can divide the complex angiogenesis process in three early events before
the blood flow is established: initiation, extension and maturation24. They are
described bellow.
Chapter 1. Introduction 8
Figure 1.5: EC’s behaviour regulation through Ang1, Ang2 and VEGF Plank et al. 25 .
Overexpression of Ang1 with respect to Ang2 renders ECs quiescent and
helps to maintain and stabilize mature vessels by promoting interaction
between endothelial cells and supporting cells like pericytes. Conversely,
the overexpression of Ang2 with respect to Ang1 blocks the stabilizing
action of Ang1 by promoting the active proliferation and migration ECs
in the presence of VEGF24.
Initiation
Angiopoietins play critical roles in angiogenic outgrowth, remodelling and matu-
ration. They are ligands for the EC-specific receptor tyrosine kinase, Tie-225. In
mature vessels, ECs are covered by perycites and kept in a quiescent state by the
presence of Ang1. Given a situation of hypoxia, like in some pathological cases,
VEGF is produced and its binding to VEGFR2 in ECs plasma membrane trig-
gers the production and release of Ang224. In opposition, Ang1 is expressed and
produced in a constant pattern by the tissue25. Ang2 can have a positive or neg-
ative effect depending on the VEGF concentration in the tissue. Overexpression
of Ang2 and a positive VEGF concentration lead to the detachment of pericytes,
giving the necessary freedom for ECs to migrate towards the source of VEGF24.
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Figure 1.6: Main signalling pathways that take part in angiogenesis. VEGF, secreted
tipically by cells in hipoxia, in particular by hipoxic tumor cells, stimu-
lates endothelial cells to release Ang2, which dispels pericytes; it actives
endothelial cells to produce PDGF-B, which induces pericyte migration
towards immature vessels; pericytes generate Ang1, which mediates en-
dothelial cell maturity.24.
Extension
EC migration and proliferation are two of the most important activities in capil-
lary extension. Migration is leaded by a tip cell while stalk cells follow the tip cell
and proliferate, adding their daughter cells to the growing sprout24. Concentration
of VEGF has influence on whether a cell gets the phenotype tip or stalk. Highest
VEGF concentrations are associated to a tip cell phenotype4. The cell-cell sig-
nalling system called Delta-Notch prevents the simultaneous activation of tip cell
in two neighbouring cells. In this process the Delta-Notch mechanism works as a
negative feedback loop where VEGF, after binding to VEGFR2, up-regulates ex-
pression of the delta like ligand 4 (Dll4) production by tip cells. Dll4 binds to Notch
receptors on neighbouring cells and results in the down-regulation of VEGFR2 re-
ceptors in the neighbour cell which dampens its migratory behaviour.4,24,26.
Finger-like projections on tip cells called filopodia are heavily endowed with
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VEGF receptors (VEGFR2), allowing them to “sense” small differences in VEGF
concentrations which the ECs use to align themselves with the VEGF gradient.
ECs also secrete metalloproteinases (MMPs), which digest the ECM creating
a pathway for the developing sprout. When a sufficient number of filopodia on
a given tip cell have anchored to the substratum, contraction of actin filaments
within the filopodia literally pull the tip cell along towards the VEGF stimulus4,20.
Vacuoles develop and coalesce in the stalk cells forming a lumen. These stalk
cells form the trunk of the newly formed capillary4.
When the tip cells of two or more capillary sprouts converge at the source of
VEGF-A secretion, the tip cells fuse together (anastomosis) to form blood-flow
supporting loops4. Due to delta-notch mediated lateral inhibition, one of the fus-
ing tip cells become inhibited and only one of them continues driving the vessel
growth26.
Maturation
When a local in the tissue receives adequate amounts of oxygen, VEGF-A levels
return to near normal. Stabilization and maturation of vascular walls requires the
recruitment of pericytes, which cover the vascular sprouts. More specifically, ECs
release platelet derived growth factor-B (PDGF-B), which promotes the prolifer-
ation of pericytes and their migration towards the capillary. Pericytes produce
Ang1 and its local concentration eventually balances the effect of Ang2. With
Ang1 dominance and pericyte coverage, ECs begin to switch from their active
phenotype back to the quiescent state, and the capillary is stabilized. Shear stress
and other mechanical signals also play a role in the stabilization/maturation pro-
cess24.
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1.2.3 Mechanical modulation
One should not forget that the study of mechanical forces is also crucial for under-
standing cell migration as is the study of the molecular players refered in 1.2.2.
The movement of a cell obeys the fundamental laws of classical mechanics. As
mentioned before, chemical signals can modulate cell mechanics (as is the case
of the effect on the MMPs on the ECM) and, at the same time, there is plenty
of evidence that mechanical forces also modulate molecular signalling through
mechanochemical feedback. In addition, by having mechanical model variables,
such as forces exerted by cells on their extracellular matrix, one has the ability
of validating not only the biological, but also the mechanical performance of the
model, in this way contributing to model fidelity27.
Biomechanical forces imposed on the vascular wall are of three major types:
tensile stress, compressive stress and shear stress (figure 1.7).
Figure 1.7: Types of biomechanical forces on the vascular wall. The direction of the
force with respect to the surface on which it is acting determines the type
of stress, which can be classified as tensile, compressive or shear stress.
This stresses constantly act on the vascular wall and are due to tension
along the vessel, pulsatile blood pressure and blood flow, respectively28.
The compressive force is generated by the blood pressure and acts perpen-
dicularly on the endothelium. The tensile force, also generated by vascular wall
expansion and contraction in response to pulsatile blood pressure changes and it
acts circumferential on the vessel wall to stretch the endothelial cells. Shear stress
results from blood flow and is a product of fluid viscosity and the velocity gradient
between adjacent layers of the blood flow29. It also induces EC shape change such
that the long axis of the cell body aligns with the direction of flow30.
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Factors like blood flow, stretch of capillaries (as a result of muscle activity30),
ECM stiffness and fluid forces have influence in the intensity of this biomechanical
forces. The explanation of their positive/negative influence in angiogenesis can be
seen on table 1.1.
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Factor Greater Smaller
Blood flow The greater the blood flow
(consequently, a greater shear
stress) the greater is the pro-
liferation of endothelial cells,
thus creating more sprouts30.
Capillaries with slow flow
gradually narrow and disap-
pear30.
Stretch Stretching of endothelial cells
induces cell division and prolif-
eration in the presence of solu-
ble growth factor29.
Non-stretched cells remain
spherical in shape, exhibit
cell-cycle arrest or even
undergo apoptosis29.
ECM stiffness The greater the substrate stiff-
ness is, the greater is the pro-
jected area of ECs. It pro-
motes the generation of trac-
tion force. The ECs prefer
cell-substrate connections than
cell-cell connections, migrating
away from each other31.
In extremely soft ECM gels,
cells may undergo apoptosis if
they cannot develop a suffi-
cient amount of tension that
is necessary for shape stability
and survival.30.
Fluid forces Interstitial flow directs sprouts
to other vessels, against the di-
rection of interstitial flow, and
consequently, toward vessels
that have higher microvascular
pressure than their own18.
Sprouts are not redirected to
other vessels.
Table 1.1: Influence of the biomechanical forces in sprouting angiogenesis.Blood flow
and stretch due to exercise influence proliferation of ECs positively and
ECM stiffness promotes migration. On the other hand, the smaller they are
the larger is the possibility for ECs to undergo apoptosis. Interstitial fluid
pressure, a solution that bathes and surrounds the cells, directs sprouts to
other vessels.
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1.2.4 Overview of mathematical models
Mathematical modelling of angiogenesis has been gaining importance as a means
of predicting sprout and growth of new vessels and/or branching/anastomosis, in
response to one or more stimulatory or inhibitory factors. Therefore, a variety of
models has been developed for the last 20 years, each focusing on different aspects
of the angiogenesis process and occurring at different biological scales - ranging
from the molecular to the tissue levels. Those models can be divided into three
categories: continuum, discrete and hybrid16,26,30.
Continuum models aim to describe the large-scale, average behaviour of cell
populations. They use partial and ordinary differential equations (PDEs/ODEs)
to describe the variation of dependent variables in space and time. One of their
advantages is that they can be discretized with standard finite difference or finite
element methods. The continuous approach provides valuable insight into the
processes of angiogenesis but they are limited in their prediction of the structure
of vascular networks6,16,30.
With discrete methods, the motion of individual ECs can be tracked over time,
and the movement is generally based on a set of rules. They use a discrete ap-
proximation in terms of the state of cells, time evolution, and/or space30. These
models offer unique capability of representing and interpreting blood vessel growth
pattern and, compared to models based on continuous PDEs, discrete models are
computationally more efficient16,30. Although, with the number of rules and inter-
actions that need to be expressed for every cell, the model can get very complex
and difficult to control. Another difficulty remains with the fact that most of the
parameters must be linked to experimental observables, a process not so simple.
Often, discrete modelling of individual cells is combined with continuous mod-
elling of the ECM and diffusing solutes (like VEGF, MMPs and fibronectin), result-
ing in a hybrid model and providing appropriate computational resolution across
various scales16. Das et al. (2010) developed a three-dimensional model for angio-
genesis, where each EC is modelled as an individual decision-making entity that
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can follow one of several state trajectories: quiescence, proliferation, migration
or apoptosis. The decision is stochastic (probability based) and is a function of
its current state, the condition of the surrounding matrix and external governing
factors, e.g., the growth factors present in neighbouring matrix. It takes into ac-
count mechanical factors such as the presence or absence of flow and initial matrix
stiffness. The mechanical factors have a global effect, in opposition with variables
like growth factor concentrations that only affect the local environment, making
this an example of an hybrid approach14.
Another hybrid approach, more similar to our model, is the one recently pro-
posed by van Oers et al. 32 . It is capable of describing the contractile forces that
endothelial cells exert on the ECM, the resulting strains in the ECM and the cel-
lular response to the strains, suffices for reproducing the behaviour of individual
endothelial cells and the interactions of endothelial cell pairs in compliant matrices.
Despite the variety of approaches that can be done, I consider that one must
not forget two important things while developing a model for angiogenesis: to
make it easy to include more angiogenic factors and also to keep the ability to
cross-talk with experimental results.
For an in-depth report on recent work in the modelling and simulation of sprout-
ing angiogenesis I refer to the recent article of review done by Heck et al. (2014)27
and references within. In the end, they conclude that there is space to improve
the actual models by extending them with a proper description of cell and matrix
mechanics, because this aspect has received, so far, little attention.
The present work of perfecting a model of angiogenesis is a step forward to the
aim of using computer simulation in the diagnosis, treatment and prevention of
disease. It is predicted that this technology will be integral to the way clinical
decisions are made in operating theaters by the end of the century33. We are still
many years away from this, but each increment we make in models for physiological
processes such as angiogenesis, relevant in disease, is a step closer.

Chapter 2
Phase-field model with elasticity
2.1 Allen-Cahn equation
We will model angiogenesis as a system with two phases (endothelial tissue and
extracellular matrix) studying their shape as a whole but not discarding the possi-
bility to track individual cells. As said in section (1.2.4), having a hybrid approach
requires less computational effort than dealing with every cell individually. Fol-
lowing a phase-field model, we can modify the governing equations to incorporate
some of the physical effects that are believed to govern the structure of a thin
interface34.
Our starting point for a theory of phase ordering (and separation) kinetics is
Allen-Cahn partial differential equation:
∂φ(r, t)
∂t
= −DδF [(φ(r, t))]
δφ(r, t)
(2.1)
We have φ(r, t) as the system’s order parameter in point r, time t, which
distinguish the two phases. The evolution of this order parameter depends on
the system’s free energy F [φ(r, t)]. The constant D refers to the diffusion of our
system and the minus signal it’s due to the fact that we want to minimize the
17
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system’s energy. This is the deterministic version of the stochastic Ginzburg-
Landau equation. By having a deterministic equation as the basis of our model,
we know that in the same conditions we must always get the same solution, which
is useful to study the effect of any change we make in our system.
The local dynamics of the system (the dynamics of an isolated cell) is governed
by the relaxational mechanism driven by the free-energy functional
F [φ(r, t)] =
∫ [
f(φ(r, t)) +
ε2
2
(5φ(r, t))2
]
dr, (2.2)
where f(φ(r, t)) is the local free energy density that can be manipulated to give
us different values for the phases’ domains. Here, the second term of the integral
is an energetic penalty for the variation of φ and forces the interface’s perimeter
to minimize. ε is the weight of this penalty.
The local free energy density used is:
f (φ) =
φ4
4
− φ
2
2
(2.3)
As we want to minimize the free energy functional, we observe that this happens
when the system has two homogeneous phases at φ = ±1 (2.1).
After calculating the derivative of the functional F (see the steps in A), we can
make the substitution in (2.1), obtaining the Allen-Cahn equation:
δφ
δt
= D
[
φ− φ3 + ε2∇2φ] . (2.4)
2.2 Conservation of the order parameter and the
Cahn-Hilliard equation
The quantity of φ can flow or move but we do not want it to disappear, i.e. we
want to conserve the integral
∫
φ(r, t) dr. Therefore, we need to have a continuity
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Figure 2.1: Free energy density curve. We can observe the double well shape of f(φ)
where the minima corresponds to the two pure phases.
equation in the basis of our diffusion equation. Continuity equations have the
following form:
δφ
δt
+∇ · j = 0 (2.5)
where j is the flux. In other words, j is the amount of φ per unit time, that crosses
a unit area, and it’s given by:
j = −D ∇δF
δφ
(2.6)
Replacing (2.6) in (2.5):
δφ
δt
= D ∇2 [φ− φ3 + ε2∇2φ] (2.7)
enables the mean value of the order parameter to remain constant throughout the
simulation, as we wanted. This is the Cahn-Hilliard equation.
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2.3 Including elasticity
We consider the following strain (2.8) and stress (2.9) tensors, for isotropic and
homogeneous materials:
εij =
1
2
(−∂juj + ∂juj) (2.8)
σij = Kεkkδij + 2µ
(
εij − 1
d
εkkδij
)
(2.9)
The elastic field u(r, t) is the displacement vector measured at a certain position
r and time t. We also have εkk as the trace of the strain tensor, associated to
the volume variation, and δij as the Kronecker symbol. The bulk modulus is
represented by K, the dimensionality of the system by d, and the shear modulus
by µ. We consider that K and d are constants of the system (d is two as we
are working in 2D), and that the shear modulus is dependent on φ, having the
following relation:
µ = µ0 − µ1φ,
where µ1 << µ0, i.e. the capillary phase, with φ = 1, has a lower shear modulus
than the ECM.
The first step is to include the elastic force F el in the free energy expression.
F el =
∫
1
2
σijεij dr (2.10)
F [φ] =
∫ [
f(φ) +
ε2
2
(5φ)2 + F el
]
dr (2.11)
The elastic force can be written in order to u(r, t) as:
F el =
∫
1
2
(
Kεkkδij + 2µ
(
εij − 1
d
εkkδij
))
εij dr
=
∫
1
2
(
Kε2kk + 2µεijεij −
2µ
d
ε2kk
)
dr
=
∫
1
2
[(
K − 2µ
d
)
(∂iui)
2 +
2µ
4
(∂iuj + ∂jui)(∂iuj + ∂jui)
]
dr
=
∫
1
2
[(
K − 2µ
d
)
(∂iui)
2 + µ(∂iuj · ∂iuj + ∂iuj · ∂jui)
]
dr.
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After calculating our functional derivative (the steps are described in Appendix
B) we conclude that:
δF el
δui
= −∂jσij = −∇σ (2.12)
The mechanical equilibrium of the system is given by ∇σ + fext = 0, where fext is
the density of applied body forces in the system. Therefore, in our system,
δF el
δui
− fext = 0. (2.13)
From this equation we extend the free energy to include the body forces. These
body forces correspond to the sum of the adhesion forces (proportional to 5φ),
and the force exerted by the tip cell. Thus, the last force is supposed to vary much
faster than φ and is considered as a constant field:
F [φ, r] =
∫ [
f(φ, r) +
ε2
2
(5φ(r, t))2 + F el − χ5 u(r, t)
]
dr (2.14)
where 5χ = −fext.
Here χ is given by the sum of the tip and adhesion contributions;
5 χ = 5(χadh + χt) = −α5 φ− f text, (2.15)
where α is a constant that characterizes adhesion and f text is the force density
exerted by the tip cell. Hence we have that χadh = −αφ and we obtain χt in
practice by solving 5χt = −f text.
After solving the zeroth and first order elastic energies (see Appendix C), we
can substitute them in 2.11:
Fel
0 =
∫ −χ2
2
(
K − 2µ0
d
+ 2µ0
) dr
Fel
1 =
∫ [
µ1φ
d
∂iiω∂jjω − µ1φ∂ijω∂ijω
]
dr
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F [φ] =
∫ [
f(φ) +
ε2
2
(5φ)2 + −χ
2
2
(
K − 2µ0
d
+ 2µ0
) + µ1φ
d
∂iiω∂jjω−µ1φ∂ijω∂ijω
]
dr
(2.16)
In Appendix D we reach the expression for the functional derivative of F . There-
fore, the Cahn-Hilliard equation can finally be modified in order to consider the
elastic properties of the system:
∂φ
∂t
= 52
[
−φ+ φ3 − ε252 φ+ αχ
L0
− µ1
(
∂ijω∂ijω − 1
d
(52ω2)
)]
+
+ 2
µ1α
L0
[
φ
d
52 (φ52 ω) + ∂ij (φ∂ijω)
]
(2.17)
where 52ω = −αφ+χt
L0
.
We can easily see that if the elastic constant µ1 is zero we nullify the elastic
terms and go back to Cahn-Hilliard equation.
2.4 Cell migration
In a physical perspective, the movement of the tip cell can be understood as a
force centred on the interface between cell membrane and ECM (see figure 2.2).
In fact, there’s no difference on whether the force is compressive or distensive. As
our domains have different rigidity, the softer domain will always be the one to
move to compensate the perturbation, regardless of its compressive or distensive
nature. Alterations in the rigid domain are more expensive in terms of energy.
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Figure 2.2: Scheme representing the direction of forces (black arrows) applied to ECM
(blue) and vessel (red) to create a compressive effect on the interface. Net
movement is made in the direction of the source of VEGF (light blue).
The softer phase occupies the deformed region in order to compensate
the perturbation.
We model the force that pulls the tip cell F(x, y), centred in the coordinates x0
and y0, as the first derivative of a 2D gaussian with an amplitude A and radius r,
F(x, y) = A
d
dx
(
e
−(x−x0)2+(y−y0)2
r2
)
ıˆ,
and χ comes from the relation:
52χt = −5 ·F = −(∂xFx + ∂yFy),
where ∂yFy = 0 because the force is being applied in the horizontal direction.
F mimics the unbalanced and polar distribution of forces across the cell-surface
contact area during cell migration (see figure 2.3)35.
In order to obtain the force field’s gradient the following second derivative is
calculated: (
e−
(x−x0)2
r2
)′′
= −
[
4(x− x0)2
r4
− 2
r2
]
e−
(x−x0)2
r2
which gives
5 ·F = −A
[
4(x− x0)2
r4
− 2
r2
]
e−
(x−x0)2+(y−y0)2
r2 . (2.18)
We may want to apply the force in another direction, other than the horizontal
one. In order to do so, we multiply the coordinates for the rotational matrix. New
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Figure 2.3: Topology of force field’s F(x, y) with r = 5 and A = 1 to mimic cellular
movement; in this case the cell is moving in the x direction.
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Figure 2.4: Topology of force field’s first derivative, χ(x, y), with an amplitude A = 5.
The negative values of χ represent a compression zone while the positive
values represent distension zones. Distension zones occur in the capillary
just before the tip cell and in the ECM just after the tip cell.
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coordinates are substituted in (2.18).
 (x− x0)′
(y − y0)′
 =
 cos(θ) −sin(θ)
sin(θ) cos(θ)
x− x0
y − y0
 =
 (x− x0)cos(θ)− (y − y0)sin(θ)
(x− x0)sin(θ) + (y − y0)cos(θ)

2.5 Chemotaxis
To provide the cues for the migration direction we must take into account chemo-
taxis. We consider the presence of the most common growth factor VEGF, in the
soluble state, and term it V . We model its concentration through the ECM with
the following equation:
∂V
∂t
= Dg 52 V − αcθ(φ)V, (2.19)
which basically is the difference between the migration by diffusion and the con-
sumption by the endothelial cells. We have Dg as the diffusion constant of VEGF,
which is consumed by the EC’s at a rate αc. The Heaviside step function allows
us to say if there is consumption of VEGF or not (it only happens inside the
capillary).
θ(φ) =
 0 if φ < 0 (outside the capillary)1 if φ > 0 (inside the capillary)
2.6 Proliferation
Angiogenesis also has a proliferative portion which is influenced by both the me-
chanical stimulus and the growth factor concentration36. Thus, any new material
added to the system would have to be dependent on these factors. Therefore, the
proliferation term is given by:
(1− φ)θ(1− φ)(θ(φ)θ(χ)kV V ), (2.20)
where kV is the proliferation constant due to the concentration of V.
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In order to mimic cell division, we want to add new matter to areas adjacent to
where vessel matter already exists. As we do not want to have new material being
added inside the vessel, where φ = 1, we use (1− φ). It dampens the proliferative
effect for increasing φ, preventing fluctuations inside the pure domain (i.e. φ > 1
instead of φ = 1)). With θ(1− φ) we totally eliminate the division effect for local
values of φ > 136.
In θ(φ)θ(χ)kV V , we use the Heaviside step function to nullify the proliferation
terms for negative values of φ and negative values of χ (corresponding to compres-
sion sites). This means we will have proliferation when V is positive, χ is positive,
and both happen inside the vessel.
Finally, our state equation is:
∂φ
∂t
= 52
[
−φ+ φ3 − ε25 φ− αχ
L0
− µ1
(
∂ijω∂ijω − 1
d
(52ω2)
)]
+
+ 2
µ1α
L0
[
φ
d
52 (φ52 ω) + ∂ij (φ∂ijω)
]
+
+ (1− φ)θ(1− φ)(θ(φ)θ(χ)kV V ) (2.21)
2.7 Parameters adjustment
Having talked about the importance of basing the model on biological experiments,
before adding any improvement we cannot forget this point. Hence, urges the
necessity of making a thorough research for all the parameters we have in the
simulation.
In what gives respect to elasticity, µ1 and µ0 are constants relatively easy to
calculate based on literature values. It depends on shear modulus, G, of ECM and
ECs:
µ0 =
GEC +GECM
2
(2.22)
and
µ1 =
GEC −GECM
2
. (2.23)
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Although it may be hard to find values for G, we are dealing with two homogeneous
isotropic linear elastic materials. This means that given two elastic moduli for each
one, the others can be calculated. After knowing µ0 we can get the value of L0:
L0 =
−
K +µ0, (2.24)
where
−
K is the average bulk modulus between ECM and ECs.
The search on elastic moduli was made having in mind that, preferably, both
should be found in the same reference. In this way, we assure that they were
obtained in the same conditions. Young modulus, E and Poisson’s ratio, ν were
found for both ECM and ECs. Therefore, G and K can be calculated according
to
G =
E
2(1 + ν)
(2.25)
and
K =
E
3(1− 2ν) . (2.26)
The value found for the protrusion force per area, F , was recently used in a
continuous model for angiogenesis, developed by Zheng et al. 24 . The amplitude
of χ, can then be obtained with
A =
F
L0
. (2.27)
Despite the fact that there is no information on literature about proliferation
rates, we collected from IBILI1’s experiments a value for kV .
We also searched for the average length of an EC, dEC . We consider that we are
working with monolayer capillaries, which means that the diameter of the initial
capillary is equal to the EC diameter.
Values found and calculated are presented in the next page’s table.
1IBILI is the Institute for Biomedical Imaging and Life Sciences, a research Institution of the
Faculty of Medicine – University of Coimbra
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Variable Value Source
EEC 4× 10−10 Nµm2 Feneberg et al. 37
νEC 0.49 Califano and Reinhart-King
38
GEC 1.34× 10−10 Nµm2 equation 2.25
KEC 6.67× 10−9 Nµm2 equation 2.26
EECM 3× 10−9 Nµm2 Raub et al. 39
νECM 0.13 Raub et al.
39
GECM 1.33× 10−9 Nµm2 equation 2.25
KECM 1.35× 10−9 Nµm2 equation 2.26
µ0 7.30× 10−10 Nµm2 equation 2.22
µ1 5.97× 10−10 Nµm2 equation 2.23
L0 4.74× 10−9 Nµm2 equation 2.24
µ1
L0
0.13 -
F 1× 10−8 N
µm2
Zheng et al. 24
A 2.1 equation 2.27
dEC 10 µm Plank et al.
25
kV 0.05 IBILI
Table 2.1: Parameters used in the simulation based on biological experiments.
The value for EECM was chosen from an interval of values that went from 500
PA to 12 000 PA.
The values proposed are reference parameters. In the simulations we may use
slightly different values.
Chapter 3
Computational simulation
For a better understanding of the model, the computational simulation is explained
in this chapter step-by-step, along with flowcharts and graphical results.
3.1 Cahn-Hilliard equation
We simulate the Cahn-Hilliard equation with FTCS (Forward-Time Centred-Space
(2.4)).
In order to do that, we first discretize the laplacian operator with a finite
difference scheme:
52 φ(i, j) = φ(i+ 1, j) + φ(i− 1, j) + φ(i, j + 1) + φ(i, j − 1)− 4φ(i, j). (3.1)
The laplacian operator is then applied to the term between square brackets in
equation 2.4. Finally, the solution of φt+dt can be obtained:
φt+dt = φt + dtD∇2 [φ− φ3 + ε2∇2φ] . (3.2)
Periodic boundaries are always considered. This means the neighbour of a point
at the boundary is at the opposite boundary.
29
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The algorithm’s structure is expressed in the flow diagram below.
Figure 3.1: Flowchart for solving the Cahn-Hilliard equation. After initializing φ
with random values near -0.21, the solution of φ in the present instant,
t, is calculated with FTCS, as explained above. After updating time,
t + dt, the same steps are repeated until we reach the stop condition
(when t = tmax).
In the simulation we see the evolution from a disordered state to the formation
of ordered domains well separated (see figure (3.2)). This arises directly from par-
ticles of the same type reorganizing themselves spatially to minimise the systems
free energy36.
Figure 3.2: Simulation on a 130 by 130 lattice mesh of the evolution of φ with D = 1,
−
φ0= −0.2 and dt = 0.02, using the Cahn-Hilliard equation, for (a) 0;
(b) 33000 iterations. In (a) we can observe the initial φ, with random
values near -0.2. In (b), the interface is visible (yellow/green). Notice the
formation of droplets of soft-phase (red) over a hard domain (blue).
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3.2 Elasticity
To model our system with elasticity (2.17), we first need to calculate the displace-
ments matrix, ω. With the Jacobian relaxation method:
ω(i, j)(n+1) = ω(i, j)(n) +
1
4
[
ω(i+ 1, j)(n) + ω(i− 1, j)(n) + ω(i, j + 1)(n) + ω(i, j − 1)(n) −
−4ω(i, j)(n) + αφ(i, j)
L0
]
,
considering that our lattice distance is one, either in the horizontal and vertical
direction. We iterate until we converge into the solution. This means, until the
difference between two successive iterations is insignificant. This equation is solved
under the boundary condition that the spatial average volume of ω is zero.
After calculating ω we do its derivatives:
∂ijω∂ijω = ∂xxω∂xxω + ∂xyω∂xyω + ∂yxω∂yxω + ∂yyω∂yyω and
∂ij(φ∂ijω) = ∂xx(φ∂xxω) + ∂xy(φ∂xyω) + ∂yx(φ∂yxω) + ∂yy(φ∂yyω).
The greater is the elasticity constant (µ1), the greater is the capability of the
soft material to deform itself and bridge close phases of the same value (see figure
3.4). This way, we prevent the system to form round domains as before.
3.3 Cell migration and chemotaxis
As the direction of migration is determined by the presence of growth factors, it
makes sense to include chemotaxis together with cell migration.
In practice, our growth factors are 2D gaussians with value 1 in the center. We
initialize a matrix, V, with the location and number of fonts we find appropriate.
In each iteration, we calculate its diffusion (2.19). The value in the center is
maintained.
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Figure 3.3: Flowchart for solving the Cahn-Hilliard equation with elastic properties.
Like φ, ω is initialized with random values near zero. The new value of
ω is obtained with successive iterations of the Jacobi’s method, until the
error between the iteration nth and (n+1)th is smaller than the tolerance.
W ’s derivatives are used to calculate the solution of φ in the instant t.
Figure 3.4: Simulation on a 130 by 130 lattice mesh of the evolution of φ with D = 1,
−
φ0= −0.2, µ = 0.071 and dt = 0.02, using the Cahn-Hilliard equation
with elastic properties, for (a) 3000; (b) 33000 iterations. The network
of interconnected soft-phase (red) formed over the hard-phase (blue) is
observable.
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In angiogenesis, an EC gets the tip phenotype when VEGF binds to VEGFR2.
In our case, the ”tip cell” is the point in the grid where we apply the force that
will be causing the migration. The direction, θ, of the force is calculated in the
tip cell, and is given by
θ = tan−1
V ′y
V ′x
,
where V ′y is the gradient of V in the vertical axis and V
′
x the gradient of V in the
horizontal axis. Now, the angle θ can be used in the rotational matrix to calculate
5·F (2.18), which will be used to obtain χ. The method is the same as to calculate
ω:
χ(i, j)(n+1) = χ(i, j)(n) +
1
4
[χ(i+ 1, j)(n) + χ(i− 1, j)(n) + χ(i, j + 1)(n) +
+χ(i, j − 1)(n) − 4χ(i, j)(n) +5 · F(i, j)(n)].
Because 52ω = −αφ+χt
L0
, the calculation of ω must be updated to include χ:
ω(i, j)(n+1) = ω(i, j)(n) +
1
4
[
ω(i+ 1, j)(n) + ω(i− 1, j)(n) + ω(i, j + 1)(n) +
+ω(i, j − 1)(n) − 4ω(i, j)(n) − αφ(i, j)
(n) + χ(i, j)(n)
L0
]
.
As in the biological case, the tip cell must be moving. To approximate our
model to reality, the position of the tip cell is changed after the force is applied
during a certain number of iterations. Starting in the position of the actual tip
cell, we follow the direction of migration searching for its new position in the
sprout. Therefore, in each iteration, we move cos(θ) in the horizontal, sin(θ) in
the vertical and calculate the weighted average of that point. We repeat this step
until we find a value near zero or negative. If it’s near zero, we have already found
an interface point, thus the new position of the tip cell. If it’s negative, it means
we passed from the EC’s phase domain to the ECM phase domain without finding
an interface point. In that case, we use the bisection method until we find the new
position of the tip cell.
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To better understand the influence of the factors we are having into account
in sprout creation, we started initializing φ with the form of a capillary. After
choosing where to apply the force, migration can be seen in figures (3.6) and (3.7)
with different directions. The value of the constants of the model is based, when
possible, in the literature. This is discussed in the next chapter.
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Figure 3.5: Flowchart for solving the Cahn-Hilliard equation with elastic properties,
cell migration and chemotaxis. New value of w is dependent not only on φ
but also on χ. After applying the diffusion equation for the growth factors
(yellow) we can calculate χ for the first iteration, having in account the
direction of migration calculated with the gradients in the tip cell. We
apply the same χ during an interval of iterations which is followed by a
cool-off period. After each cool-off period, we look for the new position
of the tip cell. Last steps, related to cell migration, are represented in
green.
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Figure 3.6: Simulation on a 130 by 130 lattice mesh of the evolution of φ with A = 5,
r = 5, L0 = 1, α = 0.13, Dg = 0.9, αc = 0.1 and µ1 = 0.13, using
the Cahn-Hilliard equation with elastic properties, cell migration and
chemotaxis, for (a) 0; (b) 9000; (c) 29000; (d) 39000; (e) 49000; (f) 52000
iterations. In few iterations we can observe the creation of a sprout that
grows in the direction of VEGF font (in light blue). Its easy to observe
the occurrence of diffusion of VEGF from (a) to (b). In (f) the necessity
of proliferation is evident: there’s disruption of the developing sprout.
Figure 3.7: Repetition of the simulation in figure (3.7) with growing of the sprout
in a different direction, for (a) 0; (b) and (d) 29000; (c) and (e) 54000
iterations. In (d) and (c) is represented χ, which is triggering movement
in (b) and (c), respectively. We can observe the inclination of χ increasing
from (d) to (e). This occurs because changes of VEGF’s gradient in the
vertical direction felt by the tip cell in (b) are less than when the tip cell
gets closer to the font.
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3.4 Proliferation
By adding the proliferation term (2.20) to the calculation of φ, even with little
proliferation as can be seen on figure 3.9, we prevent possible disruption of early
formed sprout (see figure 3.8). Despite we are considering proliferation in the
simulation, disruption can still occur if we use small proliferation coefficients.
(a)
Figure 3.8: Simulation on a 130 by 130 lattice mesh of the evolution of φ with pro-
liferation coefficient kV = 0.05, for (a) 53000 iterations. New sprout
doesn’t have an abnormal form as before and the possibility of disruption
is smaller.
(a)
Figure 3.9: Proliferation sites (light blue) from figure 3.8, for (a) 53000 iterations. It
occurs mainly in the stalk cell immediately before the tip cell.

Chapter 4
Exploring the model
In this chapter, we start by running the simulation with a greater/smaller value
for parameters like intensity of the force applied, proliferation coefficients, among
others. This way, we can study their individual influence in the overall system.
For each case, we consider as a reference the figure 3.8. We maintained the same
choice of values, except for the parameters in study. The better we know how the
system behaves in response of each stimulus, the better we know how to control,
improve and make it more robust.
After acquiring this knowledge, we study the system’s behaviour in different
situations, like the union of two sprouts. We expect the results can help us to
better understand what happens in this type of phenomenons that often occur in
the development of a vascular plexus.
4.1 Cell migration force
It was gathered from previous results of this model that by increasing the ampli-
tude, F , the main difference was the increased velocity in which the pulling effect
occurred36.
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After running the simulation with a more intense stimulus for cell migration,
another difference was evident. Not only the velocity of growth was bigger but
also the diameter of the sprout increased (see 4.1). Plus, the depression created
in the main vessel on the left side is significantly bigger.
(a) (b) (c)
Figure 4.1: Greater cell migration force, A = 15, for (a) 5000; (b) 10000; (c) 15000 it-
erations. The dark spot seen in (a) and (c) is the consequence of applying
χ. If A is excessive, disruption may occur in the place where χ is acting.
Sprouting occurs faster, but there are differences in the morphology of
the sprout and the main vessel.
(a) (b)
Figure 4.2: Smaller cell migration force, A = 1, for (a) 20000; (b) 55000 iterations.
From (a) to (b), almost any difference is noticed. This magnitude may
be insufficient to trigger sprouting.
4.2 Proliferation
Being affected by VEGF and the force applied, there are many ways to alter
proliferation.
The most obvious way to alter proliferation is by increasing the proliferation
coefficient, kV . In figure 4.3, it is observed that the sprout grew towards the VEGF
font more quickly, as expected. Despite the difference is not significant, the sprout
has a larger diameter. In the main vessel there is no noticeable change.
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(a)
Figure 4.3: Greater proliferation coefficient, kV = 0.5, for (a) 45000 iterations. It is
observable a quicker growth and a greater sprout diameter.
In the other hand, the morphology is strongly compromised with the cut-off
value considered in the Heaviside function, θ(χ) (see figure 4.4). By decreasing
its value, we say that we want proliferation to occur in a greater range of values,
including the ones where very small values of χ are present (see figure 4.5). The
consequence is a sprout with a triangular form.
(a)
Figure 4.4: Absence of a cut-off value in θ(χ), for (a) 31000 iterations. Sprout grows
with a triangular form as a consequence.
(a)
Figure 4.5: Proliferation sites (light blue) from figure 4.4, for (a) 31000 iterations.
Proliferation occurs even in the main vessel. It is stronger near the tip
cell.
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4.3 Adhesion factor, α
The parameter α controls the adhesion force between the cells. This force is
proportional to the 5φ. If α is negative, a depression is caused in the main vessel
instead of a sprout. The adhesion between cells forces the tissue to follow the
leading cell. A superior value than the one used in 3.8, causes not only the tip
cell but the material close to it to be dragged. In comparison with figure 3.6, the
disruption was prevented (see figure 4.6). The material close to the tip cell was
dragged more intensely.
(a) (b) (c)
Figure 4.6: Greater adhesion factor, α = 1, for (a) 5000; (b) 15000; (c) 25000 it-
erations. Proliferation was considered null (kV = 0) and time step was
decreased to half (dt = 0.01), in order to maintain convergence.
4.4 Regression
After a sprout grew horizontally in the direction of a VEGF font for some itera-
tions, the location of the font and the tip cell was changed to another location.
What we observed was the regression of the sprout portion where the tip cell was
previously located (see figure 4.7).
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(a) (b) (c)
(d) (e) (f)
Figure 4.7: Regression of a sprout in favour of extension in another direction, for (a)
55000; (b) 60000; (c) 65000; (d) 75000; (e) 85000; (f) 95000 iterations.
(a) The sprout grows horizontally in the direction of the VEGF gradient.
(b) VEGF’s font and tip cell position are changed. (c) and (d) Sprout’s
growth is redirected. (e) The part of the sprout where the tip cell was
previously located has regressed completely. (f) The tip cell reaches the
new VEGF font.
4.5 Anastomosis
Anastomosis is the formation of loops. It occurs after the sprout tips have migrated
some distance into the ECM and branching as taken place. Tip cells fuse either
with existing sprouts or with other tip cells. When two sprout tips fuse, a loop is
closed and migration is stopped for both tip cells (see figure 4.8). When a sprout
tip fuses with an existing sprout, a loop is closed and migration stops for the
sprout tip6.
We looked for ω, for the case of the figure 4.8. When this model was first
applied, it was discovered that ω could help us predicting what would happen in
the system36. That is what we show in the figure 4.9.
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(a) (b) (c)
(d) (e) (f)
Figure 4.8: Fusion of two tip cells, for (a) 0; (b) 40000; (c) 50000; (d) 57000; (e)
58000; (f) 61000 iterations. A sprout was created in each main vessel.
Both started growing in the direction of VEGF but the tip cells joined
before they reached the font.
(a) (b)
(c) (d)
Figure 4.9: ω before the fusion of two tip cells, for (a) and (c) 40000; (b) and (d) 45000
iterations. ω functions as guidance for future work. Greater values are
represented in dark blue and smaller values are represented in red. The
regions with larger values of ω will be occupied by φ in some iterations.
(a) ω during cool-off period. (b) ω during action of forces. (c) χ during
cool-off period. (d) χ during the action of forces.
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Looking at (b) in figure 4.9, we are able to predict in more than 10000 iterations
before that sprouts are going to fuse. We can also notice the opposite signal of ω
comparing with φ. Another important difference is the distribution and intensity
of ω when we are in a cool-off period or not (when the tip cell force is not applied).
During cool-off period, ω values are well distributed. They occur not only in the
sprouts but also in the main vessels. Yet, its values are slightly bigger in the
surrounding of the sprouts that are getting closer to each other. This may imply
that there is an attraction force between portions of the same phase field. Plus, we
can also observe that ω is more intense inside φ’s phase field than in the interface.
While forces are acting, ω is mainly concentrated in χ’s field of action.
We realized that our model fails in other cases of anastomosis. Even with
an increase in the parameters which influence positively proliferation, disruption
occurs inevitably. This can be seen either in figures 4.10 and 4.11. We considered
a notch inhibition of two cells in between the growing sprouts.
(a) (b) (c)
Figure 4.10: Double sprouting from the main vessel, for (a) 70000; (b) 90000; (c)
92000 iterations. Disruption of one of the sprouts. (a) Two sprouts
grow from the main vessel. (b) The sprout further from the font starts
disrupting. (c) The sprout further from the font disrupts.
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(a) (b) (c)
(d) (e) (f)
Figure 4.11: Double sprouting from the main vessel, for (a) 5000; (b) 50000; (c)
80000; (d) 100000; (e) 110000; (f) 113000 iterations. Disruption of the
main vessel in (f).
Chapter 5
New proliferation approach
Our model’s proliferation term is able to make a sprout grow straight but has some
limitations. It happens only in interface. This is not close to reality and revealed
to be inefficient when more than one sprout is growing.
The first step to make this new approach to proliferation was precisely to get it
closer to reality. Hence, we jumped from considering proliferation individually in a
point to consider proliferation in a cell. In practice, when calculating proliferation
in a lattice point we have in consideration its neighbours. More specifically, it
is the average proliferation of its neighbours. The neighbours considered are the
ones placed inside a circle with the radius of the cell. To avoid proliferation in
interface, we only go through points where φ is greater than 0.5.
Both chemotaxis and mechanical forces affect proliferation. Firstly, we will
study them individually with this new approach. Secondly, we will look for the
best combination between them.
It is important to highlight that all the results presented were obtained around
iteration 30 000, unless the cases where results diverged due to exaggerated pro-
liferation. Plus, when talking about conditions greater than zero, a small value of
cut-off was always used.
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Proportional with angiogenic factor concentration: Obviously, the first
criteria to have proliferation here is the presence of VEGF. Proliferation varies
directly with the quantity of VEGF until a maximum value of proliferation, Pmax
where the amount of VEGF is greater than a maximum value of VEGF, Vmax, as
shown in next figure.
Figure 5.1: Relation of proliferation with the amount of VEGF sensed in a lattice
point. The proliferation varies directly with VEGF until a maximum
proliferation value, Pmax, is reached.
No doubts arise on the antagonistic influence of Vmax and Pmax in proliferation.
While the first one is inversely proportional, the second one is directly proportional
to the proliferation at a given concentration of VEGF, as can be seen in figure 5.2.
We observe that for low proliferation there is the possibility of disruption, while
for very high proliferation also the main vessels increase their size. The range of
parameters where the new vessel is well formed is small.
The disadvantage of this approach is the increase of main vessel’s diameter.
This is easily explained: there is VEGF consumed at the main vessel and we are
considering proliferation where VEGF exists. Through literature, we know that
small calibre vessels like this do not increase diameter.
Proportional with VEGF where mechanical force exists: To avoid the
undesired result obtained before, we should select the places that are in distension.
Considering the form of χ (see figure 2.4), this means that we want proliferation
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to occur in locations of positive χ and where φ is also positive. Therefore, we add
the condition
χt(i, j)− α(φ(i, j)− 1) > 0.
This prevents the main vessel from enlarging. A small add-on like this, makes
a great difference as can be seen in figure 5.3. Here, for small proliferation there is
also disruption, but for large proliferations the new vessels are well formed without
a thickening of the main vessel.
Proportional with mechanical force: We consider proportionality with
mechanical force similar with the proportionality with VEGF. The only difference
is that instead of a maximum value of VEGF, there is a maximum value of χ. It is
an absolute value, because we want proliferation to happen on one of the positive
regions of χ.
In figure 5.4, it is clear that this approach was unsuccessful. Abnormal vessels,
in the form of a triangular shape, are created. It is difficult to find a combination
of χmax and Pmax that can create an acceptable sprout.
Proportional with mechanical force where VEGF exists: This is ob-
tained by adding the simple condition V (i, j) > 0.
The triangular form and the undesired proliferation in the left side of the main
vessel were prevented in some cases, but the region of good vessel is very restrict.
Discussion
After solving the problem with the main vessel’s dilatation, proliferation due to
VEGF in places suffering distension seemed to be a good solution. When the pro-
portionality is related to mechanical force, the values of proliferation used before
revealed to be excessive. After decreasing its value, the triangularity form is still
difficult to avoid. However, this effect is reduced when the condition to have the
presence of VEGF is included. But its still difficult to make a sprout grow straight.
Surely, the combinations of the two boosters of proliferation (VEGF and dis-
tension) results better than when one of them is acting alone. A more detailed
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study was made in order to understand which of the approaches was more robust
(see figure 5.6).
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Vmax \Pmax 0.01 0.02 0.03
0.3
0.2
0.1
Figure 5.2: Results for proliferation proportional with VEGF. It is observed an un-
desired enlargement of the main vessel.
Vmax \Pmax 0.01 0.02 0.03
0.3
0.2
0.1
Figure 5.3: Results for proliferation proportional with VEGF only where mechanical
force exists. Enlargement of the main vessel is prevented.
Chapter 5. New proliferation approach 52
χmax \Pmax 0.005 0.01 0.02
0.3
0.2
0.1
Figure 5.4: Results for proliferation proportional with mechanical force. It is observed
the creation of triangular sprouts in most of the cases.
χmax \Pmax 0.005 0.01 0.02
0.3
0.2
0.1
Figure 5.5: Results for proliferation proportional with mechanical force only where
VEGF exists. Triangular sprouts are prevented but the vessels are not
straight.
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Figure 5.6: Detailed study of each proliferation’s performance. The meanings of the
colours are the following: blue for the sprouts that disrupted, green for
the good sprouts, orange for the cases where the main vessel increased
diameter and red for tortuous/triangular sprouts. (a) Proliferation pro-
portional with VEGF. (b) Proliferation proportional with VEGF only
where mechanical distension exist. (c) Proliferation proportional with
mechanical force. (d) Proliferation proportional with mechanical force
only where VEGF exists.
The better option revealed to be the one proportional to VEGF where mechan-
ical force is acting. It was the one capable of creating good sprouts in the biggest
range of values.
Trying again to create anastomosis, the improvement from the attempts in
Chapter 4 can be observed in figure 5.7.
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(a) (b)
Figure 5.7: New attempt to create an anastomosis with the new proliferation ap-
proach (Vmax = 0.2 e Pmax = 0.03), for (a) 20000; (b) 33000 iterations.
Disruption does not occur.
Chapter 6
Conclusions and future work
Although we did not include blood pressure in the model as planned in the begin-
ning of the year, important steps were made in increasing the robustness of the
model. The first goal of this project was achieved with success. The parameters
found on literature worked well in our simulation, hence providing a more concrete
biological foothold for the model. Despite having still some constants with values
chosen by estimation, being sure about the values tested allows the development
of studies to obtain the correct values for the constants that remain unknown.
We run the simulation over a large range of values for the proliferation, testing
also different possible dependences for how the stalk cells proliferation depends
on stress and VEGF concentration. These studies enabled us to choose the best
dependence for the new proliferation approach. This method can be applied to
other parameters of the simulation.
After this year, we understand better the influence of the constant α in the
model. However, there are still doubts on how to obtain experimentally the value
to assign to this effective adhesion. Moreover, the force’s intermittency is another
factor with influence in the final result. Its frequency should also be explored
in the future. When both are understood, advances in the model can be made
more comfortably. Besides including more mechanical and biological factors, a full
angiogenesis model should also include a degree of stochasticity that is currently
not present.
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Our model is computationally heavier with the new proliferation approach.
Before creating a full parallelized code, the possibility of optimizing it by applying
implicit and higher order numerical methods should be considered.
This model can be validated by comparing its predictions with experimental
results. This should be made for example, in terms of sprouting velocity.
A three dimensional version of this model can be implemented with few al-
terations. Most of the model’s equations can describe angiogenesis in a three
dimensional environment by changing the dimension parameter d. Adapting the
search algorithm for the tip cell is what requires larger programming efforts.
The implementation of this algorithm is very complex. Whereas it requires
a lot of effort and time to improve, it is undoubtedly important to further our
understanding of the mechanic influences in angiogenesis and provide analogy
close to the real case.
Models for angiogenesis that include mechanical effects are able to explore new
treatments for diseases related to this biological process. Until now, treatments
were proposed based on chemical methods. Understanding how ECs migrate in
tissues with different stiffness may give new insights based on mechanical effects,
on how to normalize pathological vasculatures. This type of modelling coupled to
experimental validation helps to understand better how angiogenesis proceeds in
the complex in vivo environment, providing new clues on how to act upon this
complex process that is determinant for the development of many pathologies.
Appendix A
Functional derivative of free
energy, F (2.2)
In a functional derivative, instead of differentiating a function with respect to a
variable, one differentiates a functional with respect to a function. We want to
reach the following form in order to get the δF
δφ
expression:
δF =
∫
δF
δφ
δφ dr
To do that, we start by calculating F [φ+ δφ]:
F [φ+ δφ] =
∫ [
(φ+ δφ)4
4
−
(
φ+ δφ
2
)2
+
2
2
∇(φ+ δφ)2
]
dr
=
∫ [
φ4 + 4φ3δφ+ 16φ2δφ2 + 4φδφ3 + δφ4
4
− φ
2 + 2φδφ+ δφ2
2
+
+
2
2
[
(∇φ)2 + 2∇φ · ∇δφ+ (∇δφ)2]] dr
we then eliminate the δφ terms of higher order than 2, because of their approxi-
mation to zero:
=
∫ (
φ4
4
− φ
2
2
+
2
2
(∇φ)2
)
dr︸ ︷︷ ︸
F [φ]
+
∫ (
φ3δφ− φδφ+ 2∇φ∇δφ) dr︸ ︷︷ ︸
δF
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after integrating by parts with periodic boundary conditions the last term:
δF =
∫ (
φ3 − φ) δφ dr− 2 ∫ ∇2φδφ dr
δF
δφ
= −φ+ φ3 − 2∇2φ
Appendix B
Functional derivative of elastic
force, F el
Just like in A, we will calculate δF
el
δu
starting from adding an increment to the
function u from which F el depends on.
F el(u + δu) = F el(u) + δF el(u, δu)
F el(u + δu) =
∫
1
2
[(
K − 2µ
d
)
(∂i(ui + δui))
2 + µ(∂i(uj + δuj) · ∂i(uj + δuj) +
+ ∂i(uj + δuj) · ∂j(ui + δui))] dr
=
∫
1
2
[(
K − 2µ
d
)
((∂iui)
2 + 2∂iui∂iδui) + µ(∂iuj∂iuj + 2∂jui∂jδui +
+ ∂iuj∂jui + ∂iδuj∂jui + ∂iuj∂jδui)] dr
δF el(u, δu) =
∫ [(
K − 2µ
d
)
∂kuk∂iδui + µ(∂jui∂jδui + ∂iuj∂jδui)
]
dr
=
∫ [(
K − 2µ
d
)
∂kukδij + µ(∂jui + ∂iuj)
]
∂jδui dr
=
∫
∂jσijδui dr = −
∫
∂ijσjδui dr
δF el
δu
= −∂jσij
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Appendix C
Deduction of elastic energies
Consider u = u0 + u1
Order u0
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Integrating by parts:
=
∫ [(
K − 2µ0
d
)
(−∂iju0i )δu0j + µ0(−∂iiu0jδu0j − ∂iju0jδu0i ) + ∂iχδu0i
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Although we have reached an expression for δFel
0
δui
we will simplify it in order to be
easier to simulate it computationally:
u0 = ∇ω
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. (C.1)
Now, we can write a simpler equation for Fel
0 using C.1:
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Order u1
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]
dr
=
∫ [
µ1φ
d
∂iiω∂jjω +
(
K − 2µ0
d
)
∂jjω∂iu
1
i + 2µ0∂ijω∂iu
1
j − µ1φ∂ijω∂ijω + ∂iχ · u1i
]
dr
=
∫ [
µ1φ
d
∂iiω∂jjω − µ1φ∂ijω∂ijω −
(
K − 2µ0
d
)
(∂ijjω)u
1
i − 2µ0∂iijωu1j + ∂iχ · u1i
]
dr
=
∫ [
µ1φ
d
∂iiω∂jjω − µ1φ∂ijω∂ijω +
(
−
(
K − 2µ0
d
+ 2µ0
)
∂ijjω + ∂iχ
)
u1i
]
dr
=
∫ [
µ1φ
d
∂iiω∂jjω − µ1φ∂ijω∂ijω
]
dr

Appendix D
Functional derivative of free
energy with elastic force, F (2.16)
Considering the simplifications,
χ = −αφ+ χt
and
∂iiω =
χ
K − 2µ0
d
+ 2µ0
=
χ
L0
,
we can write F + δF = F [φ+ δφ] as:
F [φ+ δφ] =
∫ [
(φ+ δφ)4
4
− (φ+ δφ)
2
4
+
ε2
2
(5(φ+ δφ))2 − (−α(φ+ δφ) + χ
t)2
2L0
+
+ µ(φ+ δφ) (∂ii(ω + δω)∂jj(ω + δω)− ∂ij(ω + δω)∂ij(ω + δω))] dr
=
∫ [(
φ4
4
− φ
2
4
+
ε2
2
(5φ)2
)
+
(
4φ3δφ
4
− φδφ+ 2ε
25 φ5 δφ
2
)
−
− (−αφ+ χ
t)2
2L0
− 2δφ(−αφ+ χ
t)(−α)
2L0
+ µ1φ(
1
d
∂iiω∂jjω − ∂ijω∂ijω) +
+ µ1δφ(
1
d
∂iiω∂jjω − ∂ijω∂ijω) +
+ µ1φ
(
2
d
∂iiω
(
− α
L0
δφ
)
+ 2∂ijω∂ij
[−1
∂kk
α
L0
δφ
])]
dr
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δF =
∫ [
(−φ+ φ3)δφ+ ε25 φ · 5δφ+ α
L0
(−αφ+ χt)δφ+
+ µ1(
1
d
∂iiω∂jjω − ∂ijω∂ijω)δφ+
+ µ1φ
(−2
d
∂iiω
α
L0
δφ+
2α
L0
∂ijω∂ij
[
1
∂kk
δφ
])]
dr
=
∫ [
−φ+ φ3 − ε252 φ− α
2
L0
φ+
αχt
L0
+
+ µ1(
1
d
∂iiω∂jjω − ∂ijω∂ijω)−
− µ1φ 2α
L0d
∂ijω + µ1
2α
L0∂kk
∂ij [φ∂ijω]
]
δφ dr
We reached an expression for δF
δφ
which can be further simplified to:
δF
δφ
= −φ+ φ3 − ε25 φ− αχ
L0
+ µ1(∂ijω∂ijω − 1
d
(52ω)2)− 2µ1α
L0
(
φ
d
∂iiω +
1
∂kk
∂ij (φ∂ijω)
)
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